Shire logo

SHP - Shire News Story

4690p 0.0  0.0%

Last Trade - 04/01/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £12.25bn
Position in Universe th / 1809

BRIEF-Takeda Pharmaceutical Cancels Bridge Credit Agreement

Fri 21st December, 2018 7:42am
Dec 21 (Reuters) - Takeda Pharmaceutical Co Ltd  4502.T :
    * STATEMENT REGARDING BRIDGE CANCELLATION
    * INTENDS TO FUND CASH CONSIDERATION DUE ON COMPLETION OF
PROPOSED
ACQUISITION OF SHIRE FROM ITS CASH RESOURCES AND OTHER FINANCING
SOURCES
    * CANCELLED IN FULL REMAINING COMMITMENTS UNDER 364-DAY
BRIDGE
CREDIT AGREEMENT ENTERED INTO IN CONNECTION WITH THE ACQUISITION
ON MAY 8
    * SOME TECHNICAL AMENDMENTS BEING MADE TO TERM LOAN CREDIT
AGREEMENT DATED JUNE 8, SENIOR SHORT-TERM LOAN FACILITY
AGREEMENT DATED OCT 26

Further company coverage:  4502.T 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.